MDCO-216 Infusions Leading to Changes in Atherosclerosis: A Novel Therapy in Development to Improve Cardiovascular Outcomes - Proof of Concept Intravascular Ultrasound (IVUS), Lipids, and Other Surrogate Biomarkers Trial

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

126

Participants

Timeline

Start Date

December 3, 2015

Primary Completion Date

October 26, 2016

Study Completion Date

October 26, 2016

Conditions

Acute Coronary Syndrome

Interventions

DRUG

MDCO-216

DRUG

Placebo

Trial Locations (20)

London

Québec

Winnipeg

Brno

Hradec Králové

Prague

Budapest

Szeged

Alkmaar

Amsterdam

Nijmegen

Venlo

Bielsko-Biala

Chrzanów

Dąbrowa Górnicza

Katowice

Kędzierzyn-Koźle

Krakow

Tychy

Warsaw